HemoCue® Albumin 201 System
(This is for the Analyzer only, if you want supplies with this, please email us thru "contact us")
Used for screening and monitoring of microalbuminuria and is ideal within diabetes care, hypertension treatment and as a possible marker for preeclampsia during pregnancy.
Fast, portable and easy to use, the HemoCue® Albumin 201 System is ideal within diabetes care, hypertension treatment and as a possible marker for preeclampsia during pregnancy.
The HemoCue® Albumin 201 System is an easy, lab-accurate means of identifying microalbuminuria – long before any possible symptoms of renal or vascular complications may appear. HemoCue’s patented microcuvette technology enables quantitative test results right at the point of care. You can make immediate treatment decisions, and give direct feedback to the patient.
Certainty in vital decisions
Simple to operate, CLIA Waived device
Lab-accurate results for screening, diagnosis and monitoring
Ability to monitor changes in albumin concentration in the very low range (7-150 mg/L)
Detection of low concentrations enables early treatment to delay the onset of future microvascular complications
Fast results with ease
Ease of use with minimal training – Three simple steps
Test results in just 90 seconds
No need for lab confirmation due to quantitative results
Trusted and accepted methodology
Built on HemoCue’s proven microcuvette technology
Factory calibrated system, ensures sustainable and reliable results
Return Policy
Items are sold as-is with no returns or refunds available unless explicitly stated.
